GMED financial statements

The full income statement, balance sheet, and cash-flow statement for Globus Medical Inc. (GMED), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 135.4M2024-09 136.2M2024-12 137.5M2025-03 135.4M2025-06 135.1M2025-09 133.8M2025-12 135.3M2026-03 135.7M2026-06 134.3M-0.8% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeYoYQoQFiguresAs-reported fiscal years.

Line item	FY2025	FY2024	FY2023	FY2022	FY2021
Income Statement	as ofDec 31 ’25	as ofDec 31 ’24	as ofDec 31 ’23	as ofDec 31 ’22	as ofDec 31 ’21
Revenue	2.94B YoY+16.7%	2.52B YoY+60.6%	1.57B YoY+53.3%	1.02B YoY+6.8%	958M YoY+21.4%
	—	—	1.02B YoY+34.4%	759M YoY+5.6%	719M YoY+25.8%
Cost of revenue	958M YoY-7.5%	1.04B YoY+88.9%	548M YoY+107.9%	264M YoY+10.2%	239M YoY+10.0%
	—	—	887M YoY+67.0%	531M YoY-2.9%	547M YoY+18.9%
Research & development	147M YoY-10.1%	164M YoY+32.0%	124M YoY+69.8%	73.0M YoY-25.0%	97.3M YoY+15.2%
Selling, general & administrative	1.18B YoY+20.1%	981M YoY+52.4%	644M YoY+49.0%	432M YoY+5.9%	408M YoY+15.1%
Restructuring	—	29.7M	—	—	—
Amortization of intangibles	118M YoY-1.0%	119M YoY+133.9%	51.0M YoY+187.7%	17.7M YoY-4.3%	18.5M YoY+10.1%
Provision for credit losses	10.2M YoY-39.8%	17.0M YoY+364.4%	3.66M YoY+365900.0%	-1.00K YoY-100.1%	1.20M YoY-59.5%
Operating income	480M YoY+189.1%	166M YoY+24.7%	133M YoY-41.6%	228M YoY+32.6%	172M YoY+54.3%
Net interest income	—	-4.19M YoY-120.8%	20.1M YoY+41.4%	14.2M YoY+53.1%	9.30M YoY-33.4%
Other non-operating income	3.41M YoY+54.8%	2.21M YoY+203.1%	-2.14M YoY-215.3%	1.85M YoY-78.1%	8.45M YoY-41.6%
Pre-tax income	605M YoY+401.2%	121M YoY-27.0%	165M YoY-31.9%	243M YoY+34.7%	180M YoY+43.3%
Income tax	67.2M YoY+278.8%	17.7M YoY-58.3%	42.5M YoY-19.5%	52.9M YoY+69.3%	31.2M YoY+32.2%
	538M YoY+422.3%	103M YoY-16.2%	123M YoY-35.4%	190M YoY+27.5%	149M YoY+45.9%
Net income to common	538M YoY+422.3%	103M YoY-16.2%	123M YoY-35.4%	190M YoY+27.5%	149M
	$3.92 YoY+422.7%	$0.75 YoY-29.9%	$1.07 YoY-42.2%	$1.85 YoY+28.5%	$1.44 YoY+42.6%
EPS (basic)	$3.98 YoY+423.7%	$0.76 YoY-30.3%	$1.09 YoY-42.3%	$1.89 YoY+27.7%	$1.48 YoY+42.3%
	135M YoY-0.4%	136M YoY+20.0%	113M YoY+12.6%	100M YoY-0.3%	101M YoY+2.2%
	137M YoY-0.6%	138M YoY+20.3%	115M YoY+11.7%	103M YoY-0.9%	104M YoY+2.6%
Balance Sheet	as ofDec 31 ’25	as ofDec 31 ’24	as ofDec 31 ’23	as ofDec 31 ’22	as ofDec 31 ’21
	2.13B YoY-2.4%	2.18B YoY+13.7%	1.92B YoY+94.8%	983M YoY+13.7%	865M YoY+5.2%
Cash & equivalents	526M YoY-32.9%	784M YoY+67.9%	467M YoY+210.6%	150M YoY-22.1%	193M YoY-19.4%
Short-term investments	31.1M YoY-70.6%	106M YoY+109.2%	50.5M YoY-82.9%	296M YoY+18.1%	250M YoY+33.6%
Accounts receivable	679M YoY+21.7%	558M YoY+10.8%	503M YoY+136.0%	213M YoY+29.7%	164M YoY+16.1%
Inventory	759M YoY+15.2%	659M YoY-22.3%	848M YoY+183.7%	299M YoY+26.2%	237M YoY+3.4%
Prepaid expenses	65.4M YoY+31.8%	49.6M YoY+11.4%	44.6M YoY+112.3%	21.0M YoY+14.0%	18.4M YoY+3.6%
	5.30B YoY+1.0%	5.25B YoY+3.3%	5.09B YoY+145.0%	2.08B YoY+6.1%	1.96B YoY+16.5%
Property, plant & equipment	564M YoY+0.5%	562M YoY-4.3%	587M YoY+140.8%	244M YoY+10.2%	221M YoY+1.9%
Operating lease right-of-use	63.8M YoY+28.5%	49.6M YoY-17.2%	59.9M YoY+900.9%	5.99M YoY+19.3%	5.02M YoY+5.9%
Goodwill	1.44B YoY+0.2%	1.43B YoY-0.2%	1.43B YoY+626.5%	197M YoY+9.9%	180M YoY+14.7%
Intangible assets	745M YoY-6.3%	795M YoY-14.0%	925M YoY+1354.4%	63.6M YoY-7.4%	68.7M YoY-21.0%
Long-term investments	71.8M YoY+8.6%	66.1M YoY-12.3%	75.4M YoY-84.8%	496M YoY-11.8%	562M YoY+56.9%
Deferred tax assets	218M YoY+131.7%	94.2M YoY+781.6%	10.7M YoY-78.1%	48.8M YoY+99.4%	24.5M YoY+270.3%
Other non-current assets	78.8M YoY+4.9%	75.1M YoY-4.4%	78.6M YoY+110.6%	37.3M YoY+2.7%	36.3M YoY+13.4%
	498M YoY-41.8%	856M YoY+118.2%	392M YoY+146.4%	159M YoY+13.6%	140M YoY+16.0%
Accounts payable	98.9M YoY+31.6%	75.1M YoY+32.6%	56.7M YoY+57.0%	36.1M YoY+64.4%	22.0M YoY+20.6%
Accrued liabilities	334M YoY+28.0%	261M YoY+8.4%	240M YoY+160.9%	92.2M YoY+1.1%	91.2M YoY+16.4%
Deferred revenue	27.7M YoY+24.9%	22.1M YoY+20.5%	18.4M YoY+30.3%	14.1M YoY+17.3%	12.0M YoY+48.0%
Short-term & current debt	0.00 YoY-100.0%	443M	—	—	—
Current lease liability	14.7M YoY+43.8%	10.2M YoY-14.4%	12.0M YoY+371.9%	2.54M YoY+19.8%	2.12M YoY+13.5%
Finance lease liability (current)	348K YoY+49.4%	233K YoY-50.9%	475K	—	—
	730M YoY-32.1%	1.07B YoY-1.3%	1.09B YoY+373.6%	230M YoY+6.4%	216M YoY+24.6%
Non-current lease liability	104M YoY+24.3%	83.6M YoY-8.2%	91.0M YoY+2519.8%	3.48M YoY+18.3%	2.94M YoY+0.0%
Operating lease liability (total)	119M YoY+26.4%	93.8M YoY-8.9%	103M	—	5.05M YoY+5.2%
Finance lease liability (total)	784K YoY+47.6%	531K YoY-34.6%	812K	—	—
Finance lease liability	436K YoY+46.3%	298K YoY-11.6%	337K	—	—
Deferred tax liabilities	—	23.9M YoY-71.7%	84.4M YoY+4645.4%	1.78M YoY-58.8%	4.31M YoY-30.4%
Other non-current liabilities	21.3M YoY-0.9%	21.5M YoY-12.5%	24.6M YoY+137.8%	10.3M YoY-18.2%	12.6M YoY-14.0%
	4.57B YoY+9.5%	4.18B YoY+4.5%	4.00B YoY+116.5%	1.85B YoY+6.0%	1.74B YoY+15.6%
Additional paid-in capital	3.17B YoY+4.6%	3.03B YoY+5.6%	2.87B YoY+355.0%	631M YoY+13.9%	554M YoY+21.1%
Retained earnings	1.39B YoY+20.4%	1.15B YoY+1.4%	1.14B YoY-8.3%	1.24B YoY+3.8%	1.19B YoY+14.3%
Accumulated other comprehensive income	15.3M YoY+323.7%	-6.86M YoY+32.7%	-10.2M YoY+58.6%	-24.6M YoY-263.7%	-6.77M YoY-271.2%
Total liabilities & equity	5.30B YoY+1.0%	5.25B YoY+3.3%	5.09B YoY+145.0%	2.08B YoY+6.1%	1.96B YoY+16.5%
	135M YoY-1.7%	138M YoY+1.6%	135M YoY+35.0%	100M YoY-1.2%	102M YoY+1.8%
Cash Flow	as ofDec 31 ’25	as ofDec 31 ’24	as ofDec 31 ’23	as ofDec 31 ’22	as ofDec 31 ’21
	753M YoY+44.7%	521M YoY+113.8%	243M YoY+36.4%	178M YoY-35.4%	276M YoY+39.0%
Depreciation & amortization	277M YoY+9.3%	253M YoY+74.1%	146M YoY+113.2%	68.3M YoY-2.3%	69.9M YoY+11.1%
Intangible amortization	118M YoY-1.0%	119M YoY+133.9%	51.0M YoY+187.7%	17.7M YoY-4.3%	18.5M YoY+10.1%
Share-based compensation	49.8M YoY-8.1%	54.2M YoY+2.7%	52.7M YoY+60.7%	32.8M YoY+7.3%	30.6M YoY+13.0%
Deferred income taxes	—	-134M YoY-130.1%	-58.2M YoY-160.9%	-22.3M YoY-26.5%	-17.6M YoY-347.8%
Change in receivables	52.2M YoY-33.2%	78.1M YoY+56.4%	49.9M YoY-1.8%	50.8M YoY+96.3%	25.9M YoY+342.1%
Change in inventory	17.6M YoY-41.1%	29.9M YoY-57.5%	70.3M YoY+13.9%	61.7M YoY+415.8%	12.0M YoY-76.1%
Change in payables	8.49M YoY-52.0%	17.7M YoY+224.2%	-14.2M YoY-198.6%	14.4M YoY+291.4%	3.68M YoY+158.0%
	-355M YoY-101.7%	-176M YoY-158.1%	303M YoY+374.5%	-110M YoY+70.6%	-376M YoY-220.4%
Capital expenditure	165M YoY+42.7%	115M YoY+47.5%	78.3M YoY+5.7%	74.0M YoY+30.1%	56.9M YoY-10.6%
Free cash flow	589M YoY+45.3%	405M YoY+145.2%	165M YoY+58.2%	104M YoY-52.4%	219M YoY+62.3%
Acquisitions	253M YoY+1332.1%	17.6M YoY-94.0%	296M YoY+841.7%	31.4M YoY-8.9%	34.5M YoY+3.0%
Purchases of investments	—	114M YoY+12.8%	101M YoY-76.0%	420M YoY-32.6%	622M YoY+178.4%
Sales/maturities of investments	63.9M YoY+8.9%	58.7M YoY-75.6%	240M YoY-23.1%	312M YoY+37.0%	228M YoY+69.5%
	-679M YoY-2352.2%	-27.7M YoY+88.1%	-232M YoY-110.8%	-110M YoY-303.1%	54.1M YoY+240.0%
Long-term debt issued	0.00	0.00	0.00	0.00	0.00
Long-term debt repaid	0.00	0.00	0.00	0.00	0.00
Common stock issued	0.00	0.00	0.00	0.00	0.00
Common stock repurchased	300M YoY+250.2%	85.8M YoY-62.0%	226M YoY+56.1%	144M	0.00 YoY-100.0%
Dividends paid	0.00	0.00	0.00	0.00	0.00
FX effect on cash	22.4M YoY+8702.0%	255K YoY-88.3%	2.18M YoY+391.8%	-747K YoY+7.8%	-810K YoY-193.6%
Net change in cash	-258M YoY-181.4%	317M YoY+0.1%	317M YoY+843.7%	-42.6M YoY+8.0%	-46.3M YoY-206.1%
Income taxes paid	98.9M YoY-37.6%	159M YoY+57.6%	101M YoY+29.3%	77.8M YoY+72.8%	45.0M YoY+77.0%
Valuation Ratios	as ofDec 31 ’25	as ofDec 31 ’24	as ofDec 31 ’23	as ofDec 31 ’22	as ofDec 31 ’21
Market cap	11.8B YoY+3.8%	11.4B YoY+85.2%	6.14B YoY-17.2%	7.42B YoY+1.1%	7.33B YoY+12.7%
P/E	22.0× YoY-80.1%	110.5× YoY+184.0%	38.9× YoY-18.6%	47.8× YoY-2.8%	49.1× YoY-22.8%
P/S	4.0× YoY-11.0%	4.5× YoY-9.8%	5.0× YoY-32.6%	7.4× YoY-2.9%	7.7× YoY-7.2%
P/B	2.6× YoY-5.2%	2.7× YoY+85.7%	1.5× YoY-65.1%	4.2× YoY-0.2%	4.2× YoY-2.6%
P/FCF	20.1× YoY-28.6%	28.1× YoY-41.0%	47.6× YoY-24.3%	62.8× YoY+88.0%	33.4× YoY-30.6%
	4.6% YoY+403.1%	0.91% YoY-64.8%	2.6% YoY+22.8%	2.1% YoY+2.9%	2.0% YoY+29.5%
	5.0% YoY+40.0%	3.6% YoY+69.5%	2.1% YoY+32.1%	1.6% YoY-46.8%	3.0% YoY+44.1%
Source filing	10-K	10-K	10-K	10-K	10-K

About this data

Source: GMED's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all GMED filings on SEC EDGAR → Not investment advice.